-
The contraceptive vaginal ring (NuvaRing, Organon; West Orange, NJ) and the transdermal contraceptive (Ortho Evra, Ortho-McNeil Pharmaceutical; Raritan, NJ) have become standard options at many facilities since both were approved by the Food and Drug Administration (FDA) in 2001.
-
When it comes to prescribing an oral contraceptive (OC) for your patient, which one do you select? Participants in the 2006 Contraception Survey conducted by Contraceptive Technology Update say their No. 1 oral contraceptive (OC) of choice for a 21-year-old nonsmoker is Yasmin, a monophasic pill containing 3 mg drospirenone and 0.030 mg ethinyl estradiol from Berlex, Wayne, NJ.
-
Your next patient is a newly divorced 41-year-old woman who wants to use an oral contraceptive (OC). When you check her chart, you note that she smokes 10 cigarettes a day. What is your next move?
-
In May 2006, Hillary Clinton (D-NY) and Harry Reid (D-NV) two senators with vastly different positions on abortion stood together to introduce landmark legislation promising to significantly reduce the number of abortions in this country.
-
-
Wait and see prescriptions (WASP) is a new concept for the treatment of otitis media in children.
-
-
Because of its impact on quality of life, insomnia is one of the most common problems for which patients seek help from the primary care physician.
-
-
It is well recognized that women in whom a BRCA1 or BRCA2 mutation is identified have an accelerated risk of breast and/or ovarian cancer. Known cases generally undergo heightened surveillance and consider prophylactic salpingo-oophorectomy to reduce their risk of either or both cancers.
